IntraMed - Artículos - Manejo de la epilepsia crónica en adultos
Revisión | 06 AGO 12
Manejo de la epilepsia crónica en adultos
Se examinan las publicaciones sobre el manejo de la epilepsia crónica en los adultos.
Autor: Dres. Fergus J Rugg-Gunn, Josemir W Sander BMJ 2012;345:e4576
INDICE:  1. Artículo | 2. Referencias
Referencias

Referencias

1 Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011;77:1005-12.
2 Leone MA, Solari A, Beghi E. Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy. Neurology 2006;67:2227-9.
3 Marson A, Jacoby A, Johnson A, Kim L, Gamble C, Chadwick D. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomized controlled trial. Lancet 2005;365:2007-13.
4 Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:729-37.
5 Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon SD. Mortality from epilepsy: results from a prospective population-based study. Lancet 1994;344:918-21.
6 Lhatoo SD, Johnson AL, Goodridge DM, MacDonald BK, Sander JW, Shorvon SD. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001;49:336-44.
7 Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(suppl 5):S9-20.
8 Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1016-26.
9 Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-15.
10 National Institute for Health and Clinical Excellence. Clinical guideline 137. NICE, 2012.
11 Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-8.
12 MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000;48:833-41.
13 Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
14 Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007;62:375-81.
15 Smith D, Defalla BA, Chadwick DW. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM 1999;92:15-23.
16 Chaves J, Sander JW. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 2005;46(suppl 9):133-9.
17 Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
18 Marson AG, Hutton JL, Leach JP, Castillo S, Schmidt D, White S, et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res 2001;46:259-70.
19 Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. Differential cognitive and behaviora
effects of topiramate and valproate. Neurology 2003;60:1483-8.
20 Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1597-605.
21 Albright P, Bruni J. Reduction of polypharmacy in epileptic patients. Arch Neurol 1985;42:797-9.
22 Duncan JS, Shorvon SD, Trimble MR. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy. Epilepsia 1990;31:324-33.
23 Hosking PG, Duncan JS, Sander JW. The epilepsy nurse specialist at a tertiary care hospital-improving the interface between primary and tertiary care. Seizure 2002;11:494-9.

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Dr. Ralph Galewski   Hace más de un año
Muy respetados Doctores
Quiero felicitar muy sinceramentela manera como han manejado el tema de la epilepsia.
Permitanme, comentar otra alternativa de tratamiento. Llevo 26 anos en investigacion y practica de la electroacpuntura almemana en el area neuriologica. Dentro de los desordenes neurologicos a ser manejados esta la epilepsia, inclyendo la forma refractaria. El princvipio del tratamiento esta en identificar la causa de las convulsiones, su correspondiente manejo con la electroacuipuntura y el manejo anticonvulsivante propiamente dicho.
Afortunadamente os resultados han ido mejorando durante estos 26 anos. Invito a mi pagina web: www.electroacuüpuntura.or...
Me podria extender mas, pero creo que es bueno,parar aqui de momento
Los más...
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014